PEMETREXED 100 mg/4mL (Pemetrexed INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 100 mg/4mL

Pemetrexed 100 mg/4mL is a lyophilized powder for solution, used for intravenous administration. This medication is commonly associated with certain types of cancer treatments. Accord Healthcare Inc. manufactures this product in the USA.

Strength

100 mg/4mL

Pack Size

1 VIAL in 1 CARTON (16729-229-03) / 4 mL in 1 VIAL

Manufacturer / TM Owner

Accord Healthcare Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pemetrexed is primarily used in the treatment of specific types of cancer. It works by interfering with the growth and spread of cancer cells in the body. Pemetrexed is often administered as part of a combination therapy regimen. Patients and healthcare providers typically discuss what Pemetrexed is used for based on individual medical histories and treatment plans.

Side Effects

Common effects of Pemetrexed may include fatigue, nausea, and vomiting. Some patients may experience a decrease in blood cell counts, which can lead to increased susceptibility to infections. It is important to monitor for any unusual symptoms and report them to a healthcare provider.

Precautions & Warnings

Pemetrexed should be handled with care, as it is a potent medication. It is essential to follow proper storage and administration guidelines to ensure safety. Patients should inform their healthcare provider about any allergies or pre-existing conditions before starting treatment. Proper hydration and supplementation may be recommended to mitigate certain side effects.

Avoid Interactions

Pemetrexed may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and certain vitamins. Alcohol consumption should be avoided during treatment. Patients should consult their healthcare provider about all medications they are taking to avoid potential interactions.

Frequently Asked Questions

Pemetrexed is used in the treatment of specific types of cancer, often as part of a combination therapy regimen.

Pemetrexed is administered intravenously after reconstitution of the lyophilized powder.

Common side effects may include fatigue, nausea, vomiting, and a decrease in blood cell counts.

Pemetrexed may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Patients should follow proper storage and administration guidelines, inform their healthcare provider about allergies or pre-existing conditions, and avoid alcohol during treatment.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.